Researchers at National Jewish Health have identified an elusive trigger of type 1 diabetes. A protein fragment formed in the pancreas activates the immune system's T cells, leading them to attack and destroy beta cells, ...
Apr 9, 2019
1
845
As summer winds down, parents and children are preparing for the start of the school year, but for children with food allergies, heading to school for the first time can come with significant stress and anxiety. When a child ...
Jul 25, 2018
0
0
Eczema is the most common skin disease worldwide. People suffering from it often deal with a lifetime of painful symptoms. A new clinical trial is testing a natural treatment that researchers hope will provide a long-term ...
Apr 30, 2018
0
4
Researchers at National Jewish Health have identified 10 immune-related genes whose activity during a respiratory infection predict the long-term prognosis for cystic fibrosis patients better than conventional measures. Five ...
Mar 19, 2018
0
167
Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients. A team led by Donald Leung, MD, Ph.D., has shown that an immune system skewed toward allergy ...
Feb 27, 2018
0
7
A novel set of breathing techniques developed at National Jewish Health help athletes overcome vocal cord dysfunction and improve performance during high-intensity exercise. Vocal cord dysfunction, now also referred to as ...
Oct 16, 2017
0
51
Mepolizumab, an anti-IL5 monoclonal antibody, demonstrated significant benefits for patients with refractory cases of the rare autoimmune disease Churg-Strauss Syndrome, according to research at National Jewish Health and ...
May 17, 2017
0
0
Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings, published in the April 2017 issue of Journal of Clinical Investigation, ...
May 11, 2017
2
22156
A new study shows that a novel, nonsurgical approach to treating vocal cord dysfunction (VCD) can help 3 out of 4 adolescent athletes, who did not respond to conventional therapy, breathe better during training and competition. ...
Oct 31, 2016
0
35
Simultaneous pre-treatment with antihistamines that block both the H1 and H4 antihistamine receptors suppressed the gastrointestinal symptoms of food allergy in mice, according to researchers at National Jewish Health. The ...
May 25, 2016
0
3
